Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Now That Vivus Was Downgraded, Where Should Investors Turn?
Now That Vivus Was Downgraded, Where Should Investors Turn?
Now That Vivus Was Downgraded, Where Should Investors Turn?
Submitted by
admin
on August 20, 2012 - 11:45am
Source:
Seeking Alpha
News Tags:
Vivus
investors
obesity
Qsymia
Headline:
Now That Vivus Was Downgraded, Where Should Investors Turn?
Do Not Allow Advertisers to Use My Personal information
